Aurobindo gets USFDA approval for Risperidone Oral Solution
Drug firm Aurobindo Pharma today said it has received US regulatory approval for its Risperidone Oral Solution used in the treatment of mental and emotional problems.
By PTI |
MUMBAI: Drug firm Aurobindo Pharma today said it has received US regulatory approval for its Risperidone Oral Solution used in the treatment of mental and emotional problems.
The company has received Abbreviated New Drug Application (ANDA) approval for Risperidone Oral Solution from the US Food and Drug Administration, Aurobindo Pharma said in a filing to the Bombay Stock Exchange.
The solution is in the strength of 1 mg/ml and would be launched shortly, the filing added.
Aurobindo now has a total of 102 ANDA approvals, it added.
The company has received Abbreviated New Drug Application (ANDA) approval for Risperidone Oral Solution from the US Food and Drug Administration, Aurobindo Pharma said in a filing to the Bombay Stock Exchange.
The solution is in the strength of 1 mg/ml and would be launched shortly, the filing added.
Aurobindo now has a total of 102 ANDA approvals, it added.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
